|Articles|November 1, 2022
Supplements and Featured Publications
- Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
- Volume 28
- Issue 12
What do patients and health care providers still need to know about biosimilar medicines?
Plain Language Summary
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Shifts in Colorectal Cancer Screening Trends After COVID-19
2
Medicare Programs Observe an Increase in Participating Physicians Despite Burnout
3
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
4
Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN
5